Published in J Infect Dis on March 01, 1985
Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+ CD28- CD8+ T-cell population. Immunology (1999) 1.37
Proliferation and interleukin 5 production by CD8hi CD57+ T cells. Eur J Immunol (2008) 1.16
Tissue infiltration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus-1 infection has the phenotypic appearance of an antigenically driven response. J Clin Invest (1993) 1.07
The expanded null cell compartment in ageing: increase in the number of natural killer cells and changes in T-cell and NK-cell subsets in human blood. Immunology (1986) 1.04
Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations. J Clin Microbiol (1989) 1.03
Inverse relationship of CD8+CD11+ suppressor T cells with human immunodeficiency virus (HIV)-specific cellular cytotoxicity and natural killer cell activity in HIV infection. Immunology (1991) 0.99
Expanded T cell populations in patients with Wegener's granulomatosis: characteristics and correlates with disease activity. J Clin Immunol (1998) 0.91
Update on AIDS for the family physician. Can Fam Physician (1987) 0.88
Immunologic abnormalities related to antigenaemia during HIV-1 infection. Clin Exp Immunol (1988) 0.85
Significant enlargement of a specific subset of CD3+CD8+ peripheral blood leukocytes mediating cytotoxic T-lymphocyte activity during human immunodeficiency virus infection. Proc Natl Acad Sci U S A (1993) 0.83
High eomesodermin expression among CD57+ CD8+ T cells identifies a CD8+ T cell subset associated with viral control during chronic human immunodeficiency virus infection. J Virol (2014) 0.79
Dichotomy of two CD8+ lymphocyte subsets in HIV infection. Depletion of CD8+ CD3- and expansion of CD8+ CD3+ subsets: consequence on the CD4/CD8 ratio. Clin Exp Immunol (1991) 0.79
Abnormal T cell receptor V gene usage in myasthenia gravis: prevalence and characterization of expanded T cell populations. Clin Exp Immunol (1998) 0.75
Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol (1983) 6.39
Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med (1999) 5.82
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell (1995) 5.64
Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med (1971) 4.41
Biological expressions of lymphocyte activation. II. Generation of a population of thymus-derived suppressor lymphocytes. J Exp Med (1973) 3.50
Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet (1989) 3.37
Monoclonal antibodies against rat immunoglobulin kappa chains. Hybridoma (1982) 3.36
Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures. J Immunol (1974) 3.27
Class II MHC molecules are specific receptors for staphylococcus enterotoxin A. Science (1989) 3.03
Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr (1997) 2.92
Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor/T3 complex. Nature (1986) 2.76
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell (1999) 2.74
X inactivation in females with X-linked disease. N Engl J Med (1998) 2.67
Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet (1999) 2.63
TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc Natl Acad Sci U S A (1997) 2.52
Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis (1980) 2.50
Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet (1996) 2.29
Regulatory mechanisms in cell-mediated immune responses. I. Regulation of mixed lymphocyte reactions by alloantigen-activated thymus-derived lymphocytes. J Exp Med (1974) 2.26
Regulatory mechanisms in cell-mediated immune responses. III. I-region control of suppressor cell interaction with responder cells in mixed lymphocyte reactions. J Exp Med (1976) 2.24
An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med (1999) 2.20
Regulatory mechanisms in cell-mediated immune responses. II. A genetically restricted suppressor of mixed lymphocyte reactions released by alloantigen-activated spleen cells. J Exp Med (1975) 2.18
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood (2001) 2.15
Effect of stimulus bandwidth on the perception of /s/ in normal- and hearing-impaired children and adults. J Acoust Soc Am (2001) 2.11
Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood (1997) 2.10
Cooperative calcium binding and ATPase activation in sarcoplasmic reticulum vesicles. J Biol Chem (1980) 2.10
A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res Hum Retroviruses (1994) 1.95
Antigen presentation by major histocompatibility complex class I-B molecules. Annu Rev Immunol (1994) 1.86
Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med (1996) 1.86
Endemic infectious diseases of the Middle East. Rev Infect Dis (1991) 1.77
Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet (1999) 1.74
The process of microbial translocation. Ann Surg (1990) 1.69
Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation. J Clin Invest (1987) 1.67
A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest (1993) 1.66
Heterogeneity of clinical severity and molecular lesions in Aicardi syndrome. J Pediatr (1990) 1.62
Specialized role for a murine class I-b MHC molecule in prokaryotic host defenses. Science (1992) 1.57
Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc Natl Acad Sci U S A (1999) 1.56
Flow cytometry analysis of T cells and continuous T-cell lines from autoimmune MRL/l mice. Nature (1981) 1.56
Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood (2001) 1.55
Biological expressions of lymphocyte activation. IV. Concanavalin A-activated suppressor cells in mouse mixed lymphocyte reactions. J Immunol (1975) 1.54
Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis. Arthritis Rheum (1973) 1.53
Effect of transfer factor on lymphocyte function in anergic patients. J Clin Invest (1972) 1.52
In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol (2000) 1.51
Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. J Immunol (1991) 1.50
Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. J Immunol (1976) 1.47
Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect Immun (1993) 1.47
Idiopathic CD4+ T lymphocytopenia in a patient with mycosis fungoides. J Am Acad Dermatol (1994) 1.45
Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function. Oncogene (2007) 1.45
Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis. J Infect Dis (1971) 1.43
Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood (2001) 1.42
Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol (1998) 1.41
Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency. Proc Natl Acad Sci U S A (1988) 1.41
NKP-15: a monoclonal antibody reactive against purified human natural killer cells and granulocytes. Immunol Lett (1983) 1.40
Carrier detection in typical and atypical X-linked agammaglobulinemia. J Pediatr (1988) 1.39
Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes. Infect Immun (1994) 1.39
Influenza virus infection induces functional alterations in peripheral blood lymphocytes. J Immunol (1986) 1.35
Dextran sulphate: an adjuvant for cell-mediated immune responses. Immunology (1977) 1.33
Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta. J Exp Med (1990) 1.32
Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. N Engl J Med (1985) 1.32
Excess intrauterine fetal demise associated with maternal human immunodeficiency virus infection. J Infect Dis (1995) 1.30
Dissociation of the stimulatory activities of staphylococcal enterotoxins for T cells and monocytes. J Exp Med (1990) 1.29
A novel flow cytometric method for quantifying phagocytosis of apoptotic cells. Cytometry (1997) 1.28
Regulatory mechanisms in cell-mediated immune responses. IV. Expression of a receptor for mixed lymphocyte reaction suppressor factor on activated T lymphocytes. J Exp Med (1976) 1.27
Correlation of functional properties of human lymphoid cell subsets and surface marker phenotypes using multiparameter analysis and flow cytometry. Immunol Rev (1983) 1.27
Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J Immunol (1997) 1.27
Rapid whole-blood microassay using flow cytometry for measuring neutrophil phagocytosis. J Clin Microbiol (1992) 1.22
Staphylococcal toxins bind to different sites on HLA-DR. J Immunol (1991) 1.21
Delayed eruption of permanent teeth in hyperimmunoglobulinemia E recurrent infection syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 1.21
TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Clin Immunol (2001) 1.20
Localization of a site on bacterial superantigens that determines T cell receptor beta chain specificity. J Exp Med (1993) 1.20
Primary in vitro cytotoxic response of NZB spleen cells to Qa-1b-associated antigenic determinants. J Exp Med (1979) 1.19
H-2-nonrestricted cytotoxic responses to an antigen encoded telomeric to H-2D. J Immunol (1979) 1.19
Detection of intestinal bacterial translocation using PCR. J Surg Res (1996) 1.19
Regulation of Qa-1 expression and determinant modification by an H-2D-linked gene, Qdm. Immunogenetics (1988) 1.18
An immune defect causing dominant chronic mucocutaneous candidiasis and thyroid disease maps to chromosome 2p in a single family. Am J Hum Genet (2001) 1.18
Mutation of the disulfide loop in staphylococcal enterotoxin A. Consequences for T cell recognition. J Immunol (1991) 1.17
Fusion as a mediator of cytolysis in mixtures of uninfected CD4+ lymphocytes and cells infected by human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 1.17
Bacterial translocation: a potential source for infection in acute pancreatitis. Pancreas (1993) 1.16
Specialized functions of major histocompatibility complex class I molecules. II. Hmt binds N-formylated peptides of mitochondrial and prokaryotic origin. J Exp Med (1991) 1.15
Human immune responses to hapten-conjugated cells. I. Primary and secondary proliferative responses in vitro. J Exp Med (1978) 1.15
Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells. J Virol (2001) 1.14
Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol Cell Biol (1994) 1.13
Rapid word-learning in normal-hearing and hearing-impaired children: effects of age, receptive vocabulary, and high-frequency amplification. Ear Hear (2005) 1.13
Serious infections involving the CDC group Ve bacteria Chryseomonas luteola and Flavimonas oryzihabitans. Rev Infect Dis (1991) 1.12
Characterization and distribution of insertion sequence IS1239 in Streptococcus pyogenes. Gene (1994) 1.11
Antigen-induced murine B cell lymphomas. I. Induction and characterization of CH1 and CH2. J Immunol (1978) 1.11
Novel intraoral phenotypes in hyperimmunoglobulin-E syndrome. Oral Dis (2008) 1.10
Granuloma cytokines in murine cysticercosis. Infect Immun (1997) 1.10
The relation between stimulus context, speech audibility, and perception for normal-hearing and hearing-impaired children. J Speech Lang Hear Res (2000) 1.10
Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis. JPEN J Parenter Enteral Nutr (1995) 1.09
Dinucleotide repeat polymorphism at the DXS441 locus. Nucleic Acids Res (1992) 1.07
Regulatory mechanisms in cell-mediated immune responses. VII. Presence of I-C subregion determinants on mixed leukocyte reaction suppressor factor. J Exp Med (1979) 1.07
Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication. Gastroenterology (1996) 1.07
IL-2R gamma gene microdeletion demonstrates that canine X-linked severe combined immunodeficiency is a homologue of the human disease. Genomics (1994) 1.06
How does trp repressor bind to its operator? J Biol Chem (1991) 1.06
Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children. J Allergy Clin Immunol (2001) 1.06
Regulation of CD28 costimulation in human CD8+ T cells. J Immunol (1997) 1.06
GalR mutants defective in repressosome formation. Genes Dev (1999) 1.06
Sequential effects of prostaglandins and interferon-gamma on differentiation of CD8+ suppressor cells. J Immunol (1987) 1.04
The perception of amplified speech by listeners with hearing loss: acoustic correlates. J Acoust Soc Am (1995) 1.04
Qa-1-associated antigens. I. Generation of H-2-nonrestricted cytotoxic T lymphocytes specific for determinants of the Qa-1 region. J Immunol (1979) 1.04